Back
GILD
Gilead Sciences Inc.
🇺🇸 NYSE/NASDAQ
📈 HIGH PRICE GROWTH
👑 Overview
📈 Performance
💵 Cost
🍃 Esg
🤓 Advanced
👨👩👧👦 Community
📈
+ 8.86%
Annual Growth
5 years average annual capital growth
🌏
7
Pearlers Invested
Since January 2020
👑 Overview
Key information
🔎 Fund Overview
Gilead Sciences, Inc. is a biopharmaceutical company. The Company is engaged in advancing medicines to prevent and treat life-threatening diseases, including human immunodeficiency virus (HIV), viral hepatitis, COVID-19, cancer and inflammation. It is focused on discovering, developing and delivering medicines to address unmet medical needs in virology, oncology and other therapeutic areas. Its portfolio of marketed products includes Biktarvy, Genvoya, Descovy, Complera/Eviplera, Symtuza, Truvada, Stribild, Sunlenca, Epclusa, Vemlidy, Harvoni, Viread, Livdelzi, Veklury, Yescarta, Tecartus, Trodelvy, AmBisome, and Letairis. Its product candidates include Bulevirtide, Lenacapavir, Axicabtagene ciloleucel, Anitocabtagene autoleucel, Sacituzumab govitecan-hziy, and Domvanalimab and zimberelimab. Biktarvy is an oral formulation dosed once a day for the treatment of HIV-1 infection in certain patients. It operates in more than 35 countries worldwide.
📈 Performance
Price History*
-10.05%
1M
1Y
10Y
Graph
Table
* US price history does not take into account stock splits
Unsure how much or often to invest?
🗓️ Investing frequency calculator
Determine the investment frequency needed to reach your goals
Try it out →💵 Investing amount calculator
Determine the recurring investment needed to reach your goals
Try it out →⏱️ Investing duration calculator
Determine how long you will need to invest to reach your goals
Try it out →💵 Costs
💼
N/A
Management Fee
Included in unit price, not charged by Pearler
💸
Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator🤓 Advanced information
Technical Info
💰 Price*
$107.62
*Price may be up to 24 hours old
👩👩👦 Community Insights
How our community is investing
🌏 Pearlers invested in GILD
7
📊 Total Capital Earnings
N/A
🔃 Average investment frequency
45 weeks
💵 Average investment amount
$376
⏰ Last time a customer invested in GILD
94 days
GILD investor breakdown
💵 Income of investors
More than 200k
150k - 200k
100k - 150k
43%
50k - 100k
43%
Less than 50k
14%
👶 Age of investors
18 - 25
26 - 34
43%
35 - 90
57%
🙋 Legal gender of investors
Female
43%
Male
57%
Pearlers who invest in GILD also invest in...
🙌 Performance (5Yr p.a)
30.66%
📊 Share price
$497.45 USD
📈 HIGH PRICE GROWTH
Want more shares? Try these...
🙌 Performance (5Yr p.a)
47.11%
📊 Share price
$48.37 USD
📈 HIGH PRICE GROWTH